Active ingredient
Dextroamphetamine
62 finished FDA listings contain Dextroamphetamine as their only active ingredient; 231 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- DEXTROAMPHETAMINE, DEXTROAMPHETAMINE SACCHARATE, DEXTROAMPHETAMINE SULFATE
- Dosage forms
- Capsule, Extended Release, Patch, Extended Release, Solution, Tablet
- Routes
- Oral, Transdermal
- Manufacturers / labelers
- 17
- Strengths listed
- 10 mg/1 · 13.5 mg/1 · 15 mg/1 · 18 mg/1 · 2.5 mg/1 · 20 mg/1 · 30 mg/1 · 4.5 mg/1 · 5 mg/1 · 5 mg/5ml · 7.5 mg/1 · 9 mg/1
- Brand names in FDA listings
- Dexedrine Spansule, Dextroamphetamine Sulfate Extended-Release, Procentra, Xelstrym, Zenzedi
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 3288
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 017078 | IMPAX LABS INC | 1976-08-02 | 6 |
| ANDA 040361 | BARR | 2001-01-31 | 2 |
| ANDA 040436 | SPECGX LLC | 2002-01-29 | 2 |
| ANDA 076353 | SPECGX LLC | 2003-05-06 | 3 |
| ANDA 040776 | PRASCO | 2008-01-29 | 2 |
| ANDA 090533 | AZURITY | 2011-10-25 | 17 |
| ANDA 203901 | ACTAVIS ELIZABETH | 2012-11-30 | 3 |
| ANDA 203644 | TRIS PHARMA INC | 2013-05-29 | 2 |
| ANDA 202893 | AUROLIFE PHARMA LLC | 2013-07-31 | 2 |
| ANDA 203548 | AVANTHI INC | 2015-11-23 | 2 |
| ANDA 204330 | NOVEL LABS INC | 2016-03-16 | 2 |
| ANDA 210059 | NUVO PHARM | 2017-10-18 | 6 |
| ANDA 212160 | WINDER LABS LLC | 2021-06-07 | 7 |
| NDA 215401 | NOVEN PHARMS INC | 2022-03-22 | 4 |
| ANDA 206095 | TRIS PHARMA INC | 2022-08-18 | 2 |
Official labeling on DailyMed
- DEXTROAMPHETAMINE SULFATE TABLET [BRYANT RANCH PREPACK] · version 105 · 2026-09-11
- DEXTROAMPHETAMINE SULFATE TABLET [AUROLIFE PHARMA, LLC] · version 14 · 2026-08-24
- DEXTROAMPHETAMINE SULFATE TABLET [SUNRISE PHARMACEUTICAL, INC.] · version 13 · 2026-08-06
- DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] · version 20 · 2026-04-22
- DEXTROAMPHETAMINE SULFATE TABLET [TEVA PHARMACEUTICALS USA, INC.] · version 22 · 2026-02-23
- ZENZEDI (DEXTROAMPHETAMINE SULFATE) TABLET [AZURITY PHARMACEUTICALS, INC.] · version 14 · 2026-01-12
- XELSTRYM (DEXTROAMPHETAMINE) PATCH, EXTENDED RELEASE [NOVEN THERAPEUTICS, LLC] · version 17 · 2025-12-25
- DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE (DEXTROAMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [SPECGX LLC] · version 23 · 2025-12-12
- DEXTROAMPHETAMINE SULFATE SOLUTION [PRASCO LABORATORIES] · version 9 · 2025-11-17
- PROCENTRA (DEXTROAMPHETAMINE SULFATE) SOLUTION [INDEPENDENCE PHARMACEUTICALS, LLC] · version 17 · 2025-11-17
- DEXEDRINE SPANSULE (DEXTROAMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS LLC] · version 15 · 2025-09-29
- DEXTROAMPHETAMINE SULFATE TABLET [BRYANT RANCH PREPACK] · version 3 · 2025-08-28
Showing the 12 most recent of 27 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.